• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床共识声明:抗胆碱能药物在女性膀胱过度活动症与认知功能障碍中的相关性。

Clinical Consensus Statement: Association of Anticholinergic Medication Use and Cognition in Women With Overactive Bladder.

出版信息

Female Pelvic Med Reconstr Surg. 2021 Feb 1;27(2):69-71. doi: 10.1097/SPV.0000000000001008.

DOI:10.1097/SPV.0000000000001008
PMID:33497068
Abstract

Overactive bladder affects a significant portion of the overall population and has substantial impact on daily activities and quality of life. First-line treatment of overactive bladder includes behavioral therapies, which may be combined with pharmacologic management as indicated. Anticholinergic medications and β-3 agonists are often used as initial pharmacologic therapy, but caution should be taken in prescribing anticholinergic medications in frail or cognitively impaired patients. Recently, additional concerns have emerged regarding prolonged use of anticholinergic medications and the associated risk of cognitive impairment, dementia, and Alzheimer disease in the general population. Given the available evidence, which has shown significant associations between anticholinergic medication use and increased risk of cognitive impairment and dementia, providers should counsel on the associated risks, prescribe the lowest effective dose, and consider alternative medications in patients at risk.

摘要

膀胱过度活动症影响了相当一部分总人口,并对日常活动和生活质量产生了重大影响。膀胱过度活动症的一线治疗包括行为疗法,根据需要,这些疗法可能与药物治疗相结合。抗胆碱能药物和β-3 激动剂通常作为初始药物治疗,但在为虚弱或认知障碍的患者开抗胆碱能药物时应谨慎。最近,人们对长期使用抗胆碱能药物以及此类药物与认知障碍、痴呆和阿尔茨海默病的相关性风险产生了更多关注。鉴于现有证据表明抗胆碱能药物的使用与认知障碍和痴呆风险的增加之间存在显著关联,医生应就相关风险对患者进行咨询,开出最低有效剂量的药物,并考虑为有风险的患者开替代药物。

相似文献

1
Clinical Consensus Statement: Association of Anticholinergic Medication Use and Cognition in Women With Overactive Bladder.临床共识声明:抗胆碱能药物在女性膀胱过度活动症与认知功能障碍中的相关性。
Female Pelvic Med Reconstr Surg. 2021 Feb 1;27(2):69-71. doi: 10.1097/SPV.0000000000001008.
2
AUGS Consensus Statement: Association of Anticholinergic Medication Use and Cognition in Women With Overactive Bladder.AUGS共识声明:膀胱过度活动症女性使用抗胆碱能药物与认知的关联
Female Pelvic Med Reconstr Surg. 2017 May/Jun;23(3):177-178. doi: 10.1097/SPV.0000000000000423.
3
Characteristics of providers who prescribed only anticholinergic medications for overactive bladder in 2020.2020 年仅为膀胱过度活动症开具抗胆碱能药物的提供者的特征。
Am J Obstet Gynecol. 2023 Sep;229(3):316.e1-316.e7. doi: 10.1016/j.ajog.2023.05.024. Epub 2023 May 25.
4
The cognitive safety of antimuscarinics in the treatment of overactive bladder.抗毒蕈碱药物治疗膀胱过度活动症的认知安全性。
Expert Opin Drug Saf. 2020 Oct;19(10):1303-1313. doi: 10.1080/14740338.2020.1817377. Epub 2020 Sep 8.
5
The cognitive effect of anticholinergics for patients with overactive bladder.抗胆碱能药物对膀胱过度活动症患者的认知影响。
Nat Rev Urol. 2021 Nov;18(11):686-700. doi: 10.1038/s41585-021-00504-x. Epub 2021 Aug 24.
6
Oxybutynin-associated Cognitive Impairment: Evidence and Implications for Overactive Bladder Treatment.奥昔布宁相关认知障碍:对治疗膀胱过度活动症的影响及启示。
Urology. 2024 Apr;186:123-129. doi: 10.1016/j.urology.2023.11.033. Epub 2024 Jan 29.
7
Cognitive Effects of Anticholinergic Load in Women with Overactive Bladder.抗胆碱能负荷对女性膀胱过度活动症认知的影响。
Clin Interv Aging. 2020 Aug 25;15:1493-1503. doi: 10.2147/CIA.S252852. eCollection 2020.
8
SUFU white paper on overactive bladder anticholinergic medications and dementia risk.SUFU 白皮书:膀胱过度活动症抗胆碱能药物与痴呆风险
Neurourol Urodyn. 2022 Nov;41(8):1928-1933. doi: 10.1002/nau.25037. Epub 2022 Sep 6.
9
Increased risk of dementia among patients with overactive bladder treated with an anticholinergic medication compared to a beta-3 agonist: a population-based cohort study.与β3 激动剂相比,使用抗胆碱能药物治疗膀胱过度活动症的患者痴呆风险增加:一项基于人群的队列研究。
BJU Int. 2020 Jul;126(1):183-190. doi: 10.1111/bju.15040. Epub 2020 Mar 19.
10
Treatments for overactive bladder: focus on pharmacotherapy.膀胱过度活动症的治疗:聚焦药物治疗。
J Obstet Gynaecol Can. 2012 Nov;34(11):1092-1101. doi: 10.1016/S1701-2163(16)35440-8.

引用本文的文献

1
Posterior Tibial Nerve Stimulation With versus Without Mirabegron: A Randomized Controlled Trial.胫后神经刺激联合与不联合米拉贝隆治疗的随机对照试验。
Int Urogynecol J. 2024 Aug;35(8):1709-1717. doi: 10.1007/s00192-024-05835-y. Epub 2024 Aug 5.
2
Frailty, Specialized Care, and Sociodemographic Factors: Disparities in Oral Pharmacotherapy Class Utilization Among Medicare Part D Beneficiaries With Overactive Bladder in the United States.衰弱、专科护理和社会人口因素:美国过度活跃膀胱的 Medicare 部分 D 受益人中口腔药物治疗类别利用的差异。
Urology. 2024 Sep;191:49-56. doi: 10.1016/j.urology.2024.07.006. Epub 2024 Jul 17.
3
Cognitive effects of individual anticholinergic drugs: a systematic review and meta-analysis.
个体抗胆碱能药物的认知效应:系统评价与荟萃分析
Dement Neuropsychol. 2023 May 29;17:e20220053. doi: 10.1590/1980-5764-DN-2022-0053. eCollection 2023.
4
Inequities in Filled Overactive Bladder Medication Prescriptions in the US.美国过度活跃膀胱填充药物处方中的不平等现象。
JAMA Netw Open. 2023 May 1;6(5):e2315074. doi: 10.1001/jamanetworkopen.2023.15074.
5
Despite Recommendations, Anticholinergics Account for the Majority of Prescriptions to Treat Overactive Bladder in the United States.尽管有相关推荐,抗胆碱能药物在美国仍是治疗膀胱过度活动症的主要处方药物。
Urogynecology (Phila). 2023 May 1;29(5):497-503. doi: 10.1097/SPV.0000000000001301. Epub 2022 Nov 12.
6
Multi-Disciplinary Management in Rectal Cancer Survivorship: A Clinical Practice Review.直肠癌康复多学科管理:临床实践综述。
J Gastrointest Cancer. 2023 Dec;54(4):1102-1115. doi: 10.1007/s12029-022-00885-1. Epub 2023 Jan 9.
7
Female Urinary Incontinence Evidence-Based Treatment Pathway: An Infographic for Shared Decision-Making.女性尿失禁循证治疗路径:用于共同决策的信息图。
J Womens Health (Larchmt). 2022 Mar;31(3):341-346. doi: 10.1089/jwh.2021.0266. Epub 2021 Nov 5.